INTRODUCTION
The therapeutic rationale for molecularly targeted radiotherapy (mTRT) is the selective delivery of a radionuclide to tumor cells via a targeting moiety, thereby enhancing the therapeutic index of the agent. Several Auger electron (AE) emitting radionuclides have been proposed for mTRT of small metastases and disseminated cancer cells with some promising clinical results (1) (2) (3) . These radionuclides are well suited for mTRT agents due to the extremely short range in matter (nanometers to a few micrometers) of the low-energy, intermediate linear energy transfer (LET) Auger and Coster-Kronig (CK) electrons they emit (4) . These electrons account for high energy deposition in the immediate vicinity of the decay site and, owing to their short range, irradiation of normal neighboring cells is limited, thus reducing non-specific radiotoxicity. In addition, radiation emitted during the nuclear decay can be exploited for imaging purposes either with single photon emission computed tomography (SPECT in the case of γ-rays in the energy range of 70 -360 keV or Bremsstrahlung imaging for pure β --emitters) or positron emission tomography (PET in the case of annihilation photons), thus making AE emitting radionuclides ideal as theragnostic agents (5, 6) .
When evaluating AE emitting radionuclides as potential theragnostic agents, the following aspects should be addressed. The therapeutic efficacy of a radionuclide depends on the total number of electrons emitted per decay (including AE, CK and internal conversion electrons (IE) as well as β-particles) along with the total energy released. When the total energy released is carried by a small number of relatively high-energy long-range electrons, then targeting of the nucleus from the cytoplasm or cell surface is possible (7) . Another key factor is the physical half-life (T p½ ). As the maximum theoretical specific activity of a radionuclide is inversely proportional to T p½ , a prolonged T p½ may result in redistribution of the therapeutic agent before sufficient decays have occurred to cause lethal damage. It is also important to consider the ratio of penetrating (x-and γ-ray) to non-penetrating (electron or β-particle) forms of ionizing radiation (p/e) because the moderate-high energy but low LET γ-emissions from some radionuclides could irradiate and potentially kill non-targeted normal cells. It has therefore been proposed that an ideal therapeutic radionuclide should have a (p/e) ratio of 2 (8) . Conversely, for imaging purposes a high proportion of γ emissions is required, which poses a trade-off between sparing healthy tissue surrounding the target region and providing adequate mean absorbed dose to the target region.
The most critical point to consider when using AE emitting radionuclides for mTRT is the very short range of Auger and CK electrons as this necessitates intra-nuclear accumulation if maximum therapeutic effect is to be achieved. Since the dimensions of the different DNA condensation states (e.g., chromatin fibers, nucleosomes and double-stranded DNA) are all within the range of typical Auger and CK electrons, nuclear incorporation leads to extreme radiotoxicity, resembling high-LET radiation with relative biological effectiveness (RBE) similar to that achieved by α-emitting radionuclides (9) . Several strategies have been proposed to achieve the optimal localization of the radionuclides with respect to the sensitive targets in cells (5, 10, 11) . However, recent by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from observations suggest that nuclear accumulation may not be required for an Auger electron emitter to produce high-LET type radiotoxicity (12) . In contrast, radionuclides bound outside the cell nucleus, e.g. in the cytoplasm, on the cellular membrane or extra-cellularly, do not produce severe lethal effects, and have RBE values comparable to those observed for low-LET radiation (13) .
Regardless of the targeting strategy adopted, cellular geometry could influence the mean absorbed dose to the nucleus and thus the biological effect of an AE emitting theragnostic agent. The S-value estimates provided by the MIRD Committee (14) assume spherical cell geometry, but it is conceded that cellular geometry could affect these values. This was demonstrated by Nettleton and coworkers (15) who noted differences between S-value calculations in spherical and ellipsiodal cell geometries especially towards the edge of the cell. Considering that many cells exhibit irregular geometries and eccentric cell/nucleus arrangements, dose to the nucleus may be over or underestimated when using MIRD tabulated S-values. Ra.
MATERIALS AND METHODS

Monte Carlo simulations -The PENELOPE code
The S-values and DPKs were calculated with the general-purpose Monte Carlo code PENELOPE (19) . PENELOPE simulates the coupled electron/photon transport in arbitrary materials from 50 eV to 1 GeV. The simulation is controlled by seven user-defined parameters: Eabs(1), Eabs(2), Eabs(3), C1, C2, Wcc and Wcr.
The first three parameters fix the absorption energy for electrons, photons and positrons defining the cut-off energy below which simulation is discontinued (50 eV) and the residual energy of the particle is deposited locally. The remaining parameters control the mixed simulation algorithm for the transport of electrons and positrons. To force detailed (event-by-event) simulation the latter parameters were set to zero (20) .
The cell model consists of two homogeneous spheres of liquid water (mass density ρ = 1 gcm (14) were considered, and the list of (R C , R N ) values was expanded to include larger cell geometries (up to R C = 12 µm and R N = 11 µm) (21) . Typically 2x10 9 primary particles were simulated in each run.
S-value Calculations
MC transport of the complete radiation spectra based on the unabridged nuclear decay data (RADTABS Tc, the full β-spectra were included. The Auger, CK and IE electrons as well as β particle contributions to S-values were determined separately. Taking the nucleus as the target, simulations were run assuming uniformly distributed activity in the nucleus (N←N), in the cytoplasm (N←Cy) or on the cell surface (N←CS). Cellular S-values, that is, the mean absorbed dose to the target region (T) per unit cumulated activity in the source region (S), i.e. S(T←S), according to the MIRD formalism is
where is the number of electrons ( Sb not included in the MIRD monograph, were compared with those in the MIRD tabulations (14) derived from equation (2) . The S-value in the continuous-slowing-down, straight-trajectory approximation is given by
where ← ( ) is the geometric reduction factor (14), ( ; ) is a semi-empirical electronic (collision) stopping power of an electron with initial energy after passing a distance through the medium and r CSDA is the range in the continuous-slowing-down approximation.
DPKs
For DPKs a point isotropic radiation source was placed in an infinite liquid water medium and the mean absorbed dose from the emitted electrons (AE, CK, IE and β particles) was scored in 1nm-thick spherical shells around the decay site. Mean absorbed doses were tallied up to a radial distance of 30 µm from the point source.
This corresponded to the radius of a sphere in which 100% of all emitted energy from the AE+CK-spectra was absorbed for
To compare the dose deposition of the radionuclides to that of 223 Ra (22) , the ratio of the DPKs calculated for spheres representing different DNA condensation states was determined. The energy deposited by the 5.77 MeV α particles was approximated by multiplying the mass electronic stopping power (800 MeVcm 2 /g) over the path length (i.e. the radius of the sphere), while energy deposition of the AE+CK+IE spectrum was determined by event-by-event simulation. 
RESULTS
MC Calculated S-values
Effect of Cellular Geometry on S-values
The effect of cellular geometry on the S-values, taking into account only contributions from the AE+CK+IE spectrum is summarized in Supplemental Tables 2-13. The self-dose to the nucleus is obviously not influenced by the position of the nucleus relative to the cell (concentric vs. eccentric nucleus arrangements) or the shape of the cell. However, the position of the nucleus, especially for eccentric arrangements can contribute significantly by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from to crossfire of neighboring cells, and this would specifically be seen for radionuclides with longer range AE and IE. Generally, the contribution to S(N←Cy) is less for eccentric compared to concentric cell arrangements, with the greatest differences (up to 30%) noted in smaller (R C , R N ) configurations. These differences become less pronounced (< 10%) when (R C , R N ) increase. For eccentric vs. concentric nuclear arrangements where the activity is uniformly distributed on the cell surface, the greatest contribution to the mean absorbed dose delivered to the nucleus is again seen for small R N relative to R C (see Supplemental Figure 2 , R C = 5 µm and R N = 2 µm). It follows that S(N←CS) contributions in eccentric nucleus configurations increases as the size of the nucleus decreases and thus the distance of the nucleus from the cell surface decreases in relation to the range of the particles. This is particularly apparent for 89 Zr (Supplemental Figure 4) , where up to a 60 fold increase in nuclear dose is observed for R C =10 µm and R N = 5 µm. However, this effect decreases when including the contribution from the β-spectra (Figure 2A 
Contribution of AE to S-values
Self-dose to the nucleus for the majority of radionuclides studied is almost exclusively due to AE, with IE (and where appropriate β particles) responsible for the remaining mean absorbed doses (Supplemental Tables 2-13 Figure 4B ). In general, the relative dose of the AE-emitting radionuclides diminishes dramatically as diameters representing DNA condensation states increases.
DISCUSSION
To evaluate the virtues of AE emitting radionuclides that have previously been suggested for therapeutic or imaging purposes, a single-cell dosimetric approach was undertaken by considering all energy deposition events and related probabilities. Firstly, cellular S-values were determined by MC transport of all particulate radiation following the MIRD formalism and secondly DPKs were calculated for all the radionuclides considered in 1 nm radial bins up to 30 µm. In this regard it is crucial to use an MC code that provides an event-by-event simulation, as a loss of spatial resolution during particle transport from condensed simulation algorithms (i.e. grouping elastic, inelastic and radiative events), and underestimation of secondary electrons, have a large effect on energy deposition (23) . PENELOPE can carry out event-by-event coupled photon-electron transport simulations, thus providing a more accurate estimation of the energy deposition than other general-purpose MC codes (24, 25) .
PENELOPE cellular S-values for overlapping source and target areas are in good agreement with MIRD and those previously published (26), with differences < 10 and 5%, respectively. However, larger discrepancies are by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from seen when the source and target volumes are further apart. The greatest difference (up to 60%) between PENELOPE and MIRD S-values was for the case where activity was assumed to be distributed on the cell surface in accordance with previous observations by Uusijärvi et al (25) . These differences can be ascribed to MIRD S-values being based on approximate DPKs calculated from the collision stopping power (i.e. assuming straight electron trajectories and neglecting energy straggling). Differences could also be attributed to the different energy spectra used. Whereas the unabridged radiation spectra from the MIRD monograph (22) was adopted in the MC simulations, MIRD S-values were generated from the energy spectra provided by Eckerman and co-workers (27) . A limitation of the PENELOPE code when transporting AE, is the set cut-off energy of 50 eV. Many of the radionuclides evaluated here have an abundance of low-energy AE, less than 50 eV, which are thus not transported. This could potentially lead to an overestimation of energy deposited within the first few nm shells of the DPKs calculated.
It was recently demonstrated that a small variation in mean absorbed dose could have a significant impact on tumor control probability (28) . It is therefore crucial that the selection of a radionuclide-delivery vehicle addresses not only the distribution (particularly internalization) of the radionuclide but also the geometry of the targeted cells. As is shown, eccentric cell-nucleus arrangements can lead to increased S-values for some of the radionuclides studied here. The greatest effect of nucleus eccentricity was noted for S(N←CS) configurations. The spatial dose gradients in the respective DPK spectra are the result of the end of ranges of major lowenergy electron groups. The sharp drop in dose after the first few nm illustrates the highly localized energy deposition caused by the AE, with local mean absorbed doses over this range in excess of 10 MGy. Radial dose distributions diverge by less than 25% compared to that previously reported for 111 In and 125 I (29, 30) , and could be ascribed to the different radiation spectra used.
Although β-emitters are clinically widely used because of their long range, the recent success of the α-emitting radionuclide 223 Ra (31) has focused attention on the use of shorter range radionuclides for mTRT. From the viewpoint of their cell-killing potential, the advantage of AE-emitting radionuclides is their extremely short range and localized dose deposition. Intranuclear delivery of AE-emitting constructs results in RBE similar to that of α-emitters, but with a reduced crossfire effect compared with α-emitters, making them more suitable for single-cell irradiation (9) . The DPKs of in spheres of DNA dimensions, only the higher mass number AE-emitters deposit comparable amounts of energy. While, comparison with a monoenergetic 5.77 MeV alpha particle notes the major advantage of AEemitters at distances < 11 nm, which is in agreement with data presented by Charlton (32) .
CONCLUSION
Many AE-emitters are suitable for theragnostic applications, enabling simultaneous detection (PET and SPECT imaging) and treatment. New strategies are being developed for delivery of AE-emitting radionuclides to the cell nucleus, e.g. carbon nano-tubes (33), gold nano-particles (34), antibody based (35) and cell penetrating peptides (36) . The data presented here suggest that single cell characteristics should be taken into account when designing these molecularly targeted agents. The challenge will be to match the delivery strategy with the physical properties of a particular radionuclide.
by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from
